Clinical Trials on Aeromonas Spp. Infections in Germany

Total 2493 results

AO Clinical Investigation and Publishing Documentation

Completed

Clinical Priority Program-Bone Infection Registry (CPPInfection)

Staphylococcus Aureus | Bone Infection

United States, Belgium, Denmark, China, Argentina, Germany, Japan, Switzerland, Austria, Canada
UMC Utrecht
Janssen Research & Development, LLC; Innovative Medicines Initiative

Completed

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli-2 (EXPECT-2) (EXPECT-2)

E. Coli Infection

United States, Italy, United Kingdom, Canada, France, Germany, Japan, Spain
Pfizer

Completed

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

Encephalitis, Tick-Borne

Germany, Austria, Poland
GlaxoSmithKline

Completed

Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.

Skin Infections, Bacterial

United States, Germany, Taiwan, Netherlands, Argentina, Chile, Costa Rica, South Africa, Mexico
Gilead Sciences

Completed

Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment

HCV Infection

United States, Germany, New Zealand
Valneva Austria GmbH
PATH

Completed

Open-Label Study Assessing The Safety, Immunogenicity and Dose Response of IC47

Pneumococcal Infections

Germany
Heinrich-Heine University, Duesseldorf
German Research Foundation

Completed

Staphylococcus Aureus Bacteremia Antibiotic Treatment Options (SABATO)

Staphylococcus Aureus Infection

France, Germany, Netherlands, Spain, United Kingdom
Charite University, Berlin, Germany
Rheumazentrum Ruhrgebiet

Unknown

Etanercept (Enbrel) in Undifferentiated Spondyloarthritis (Enbrel_uSpA-2)

Spondyloarthritis

Germany
Charite University, Berlin, Germany

Completed

Referral Recommendations for Axial Spondyloarthritis

Ankylosing Spondylitis | Spondyloarthritis | Spondyloarthropathy

Germany
NEAT ID Foundation

Terminated

International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response (NECTAR)

COVID-19 | Coronavirus Infection | SARS-CoV2 Infection

Germany, Spain, Brazil, Italy, South Africa
Hendrik Streeck
Federal Ministry of Health, Germany; US Military HIV Research Program; German... and other collaborators

Completed

HIV and STIs Clinical Study in Germany

HIV Infections | Sexual Behavior | Risk Reduction

Germany
Valneva Austria GmbH

Completed

Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study

Japanese Encephalitis

Australia, United States, Germany
Geert Wanten
Geistlich Pharma AG

Completed

Clinical Trial With Catheter Locking TauroSept® (Taurolidine 2%) or Saline Solution 0,9%

Catheter Related Blood Stream Infections

United Kingdom, Israel, Denmark, Germany, Italy, Netherlands
Goethe University

Completed

Prospective Electroencephalography Evaluation of Sedation in COVID-19

Pathologic Processes | Acute Respiratory Distress Syndrome | Corona Virus Infection | Electroencephalogram | Conscious Sedation

Germany
Bionor Immuno AS

Completed

Re-boosting of HIV-1 Infected Subjects With Vacc-4x (Re-boost)

HIV-1 Infection

United States, Spain, Germany, Italy, United Kingdom
Novartis Vaccines
GlaxoSmithKline

Completed

A Phase 3b, Single-Center, Open-label Study to Assess the Immunogenicity and Safety of Novartis Meningococcal B Recombinant Vaccine When Administered at a 0, 2-Month Schedule in Healthy At-Risk Adults Aged 18 to 65 Years Inclusive.

Prevention of the Meningococcal Disease

Germany
Da Volterra
Syneos Health

Completed

Safety and Efficacy of DAV132 in Patients at High-Risk for Clostridium Difficile Infection (CDI) (SHIELD)

Clostridium Difficile Infection

Bulgaria, Germany, Romania, Serbia
Bitop AG

Completed

Treatment of Respiratory Tract Infection and/or Acute Bronchitis With Ectoin Inhalation Solution

Cough | Bronchitis | Dyspnoea | Sputum, Cellular Atypia

Germany
Charite University, Berlin, Germany

Unknown

Methicillin-sensitive and Methicillin-resistant Staphylococcus Aureus (MSSA/MRSA) - Point-of-care-testing (POCT) in Clinical Decision Making (EPICS-6)

Staphylococcus Aureus

Germany
Wuerzburg University Hospital

Completed

Perioperative Change of Regional Ventilation During Spontaneous Breathing

Pneumothorax | Respiratory Insufficiency | Pleural Effusion | Atelectasis | Pulmonary Infection | Bronchospasm | Aspiration Pneumonitis

Germany
University of Cologne
3M

Completed

Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer Patients (COAT)

Bloodstream Infection

Germany
Charite University, Berlin, Germany
Rheumazentrum Ruhrgebiet

Unknown

Etanercept (Enbrel) in Ankylosing Spondylitis (Enbrel_AS-2)

Ankylosing Spondylitis

Germany
Charite University, Berlin, Germany
Bristol-Myers Squibb

Unknown

Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis (Aba-AS-01)

Ankylosing Spondylitis

Germany
Charite University, Berlin, Germany
Abbott

Unknown

D2E7-Early AS

Ankylosing Spondylitis

Germany
Charite University, Berlin, Germany

Unknown

Prednisolone in Active Ankylosing Spondylitis (AS)

Ankylosing Spondylitis

Germany
BioNTech SE

Recruiting

Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers

Tuberculosis

Germany
University Hospital Muenster
Baxter Healthcare Corporation

Recruiting

Filter Lifespan in Continuous Renal Replacement Therapy (CRRTInfO)

Infections | Critically Ill | Continuous Renal Replacement Therapy

Germany, Austria, Brazil
Janssen Research & Development, LLC

Completed

A Study of Cetrelimab in Participants With Chronic Hepatitis B Virus Infection

Hepatitis B, Chronic

France, Germany, Spain, Poland, Belgium
CureVac

Completed

Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults

Rabies

Germany
CureVac

Completed

RNActive® Rabies Vaccine (CV7201) in Healthy Adults

Rabies

Germany
Charite University, Berlin, Germany
Hoffmann-La Roche

Unknown

Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis

Ankylosing Spondylitis

Germany
Heidelberg ImmunoTherapeutics GmbH

Terminated

Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 1 Infection (MATCH-1)

Herpes Labialis

Germany
MUC Research GmbH
Merck Sharp & Dohme LLC; Pfizer; AbbVie; German Center for Infection Research

Completed

New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients (NewEra)

HIV Infections

Germany
Marylyn Addo
Charite University, Berlin, Germany; University of Cologne; Ludwig-Maximilians... and other collaborators

Completed

Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S

MERS (Middle East Respiratory Syndrome)

Germany
LimmaTech Biologics AG

Completed

Phase I to Test a New Pneumococcal Vaccine

Pneumonia, Bacterial | Pneumococcal Pneumonia

Germany
Alexion Pharmaceuticals

Completed

A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP)

Hypophosphatasia (HPP)

United States, Taiwan, United Kingdom, Australia, Canada, Germany, Spain
Pascoe Pharmazeutische Praeparate GmbH

Recruiting

Vitamin C as add-on Therapy in Patients With Acute Herpes Zoster

Neuropathic Pain

Germany
Bristol-Myers Squibb

Completed

Comparative Assessment of Utilization of Antiviral Therapies in Hepatitis C and Effectiveness of Daclatasvir-containing Regimens in Real-life Clinical Care in Europe (CMPASS-EU)

Hepatitis

Germany
University of Regensburg

Unknown

Immune Monitoring of Hepatitis C Under DAA Therapy (IMHC)

Hepatitis C

Germany
University Hospital Tuebingen
Universitätsklinikum Hamburg-Eppendorf; Robert Bosch Medical Center; Bernhard...

Terminated

Hydroxychloroquine for the Treatment of Mild COVID-19 Disease (COMIHY)

COVID-19

Germany
Universitätsklinikum Hamburg-Eppendorf

Completed

Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19 (CYTOCOV-19)

COVID-19

Germany
Bayer

Completed

Avelox in Complicated Skin and Skin Structure Infections (ARTOS)

Skin Diseases, Bacterial

Germany, Indonesia, Korea, Republic of, Saudi Arabia, Philippines, Taiwan, Austria, Bulgaria, Slovenia, Egypt, Greece, Pakistan
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older

Herpes Zoster

Germany, Canada, United States
Corat Therapeutics Gmbh

Recruiting

Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19

Covid19

Germany
Charite University, Berlin, Germany
Allergan

Terminated

Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients

Covid19

Germany
Universitätsklinikum Hamburg-Eppendorf
Ludwig-Maximilians - University of Munich; Philipps University Marburg Medical... and other collaborators

Completed

Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19

Covid19

Germany
Bristol-Myers Squibb

Completed

Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients

Hepatitis B, Chronic

Germany
Charite University, Berlin, Germany

Recruiting

Characterization and Verification of the Intensive Care Standard Operating Procedure (SOP) Adherence of the Treated COVID-19 Patients

Covid19

Germany
Drägerwerk AG & Co. KGaA

Terminated

Dräger COVID-19 Antigen Test Clinical Performance Study

Covid19

Germany
Charité Research Organisation GmbH
Bayer

Terminated

Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat (NICCAM)

Covid19

Germany

Clinical Trials on Aeromonas Spp. Infections in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations